Features Partner Sites Information LinkXpress
Sign In
Advertise with Us


05 Mar 2017 - 09 Mar 2017
20 Mar 2017 - 23 Mar 2017
12 Apr 2017 - 14 Apr 2017

Sartorius Acquires US Start-up ViroCyt

By BiotechDaily International staff writers
Posted on 22 Jul 2016
Sartorius AG (Göttingen, Germany), a pharmaceutical and laboratory equipment provider, has acquired ViroCyt Incorporated (Broomfield, CO, USA), a start-up in the field of rapid virus quantification, in a deal valued at approximately USD 16 million.

ViroCyt’s automated platform integrates instruments, software and reagents to deliver faster results in comparison to commonly used methods for virus counting. The company’s key customers include pharma and biopharma R&D laboratories, vaccine manufacturers and academic institutes focused on virology.

In June this year, Sartorius had acquired IntelliCyt Corporation (Albuquerque, NM, USA) a manufacturer of cell screening platforms used in drug discovery, for USD 90 million in cash. The acquisition was a part of Sartorius’ efforts to expand its current lab portfolio into bio analytics, thereby strengthening its offering for the company’s biopharma customers and academia.

Michael Melingo, member of the Sartorius Group Executive Committee, said, “After acquiring the cell screening specialist IntelliCyt, we are now adding a further very innovative bioanalytical tool to our Lab Products & Services portfolio that will enable our customers to obtain lab results much faster and reduce the time to clinic for virus-based pharmaceuticals.”

“Sartorius is an ideal partner for us due to its global presence and strong reputation for innovation and quality. By joining forces, we will drive further adoption of our novel approach to virus quantification both in the US and in international markets,” said Robert Kline, President and CEO of ViroCyt.

Related Links:



view channel
Image: A photomicrograph of a thyroid gland section: (1) follicles, (2) follicular cells, (3) endothelial cells (Photo courtesy of Wikimedia Commons).

Novel Method Enables Generation of Thyroid Tissue from Mouse Stem Cells

A novel method for generating thyroid cells (thyrocytes) from embryonic stem cells was demonstrated in a mouse model. The dysfunctional thyroid gland can lead to severe disease such as Grave's disease... Read more


view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more
Copyright © 2000-2017 Globetech Media. All rights reserved.